Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery

NCT02958566 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-03-20

No results posted yet for this study

Summary

The General Objective of this study is to investigate the cost and efficacy of treating patients undergoing colorectal surgical resections with an opioid limited pain control regimen as part of an Enhanced Recovery After Surgery (ERAS) Protocol. This group will be compared to a traditional opioid based pain control regimen.

Conditions

  • Colon Cancer
  • Colon Diverticulosis
  • Colonic Neoplasms
  • Colonic Diverticulitis
  • Pain, Postoperative
  • Ileus
  • Ileus Paralytic
  • Ileus; Mechanical
  • Constipation Drug Induced
  • Constipation
  • Rectum Cancer
  • Rectum Neoplasm

Interventions

DRUG

Gabapentin

DRUG

Orphenadrine

DRUG

Lidocaine

DRUG

Marcaine

DRUG

Ketamine

DRUG

Methadone

DRUG

Tramadol

DRUG

Ketorolac

DRUG

Morphine Sulfate

DRUG

Fentanyl

DRUG

Dilaudid

DRUG

Hydrocodone-Acetaminophen Tab 5-325 MG

DRUG

Morphine Sulfate

PCA

DRUG

Fentanyl

PCA

DRUG

Dilaudid

PCA

DRUG

HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET

Breakthrough

Sponsors & Collaborators

  • University of Illinois College of Medicine at Peoria

    lead OTHER

Principal Investigators

  • Steven S Tsoraides, MD, MPH · University of Illinois College of Medicine at Peoria

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02958566 on ClinicalTrials.gov